Quantumzyme Corp. (QTZM)

Quantumzyme Balance Sheet

Financials in millions USD. Fiscal year is August - July.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Oct 31, 2025	Jul 31, 2025	Jul 31, 2024
Cash & Equivalents	0	0	-
Cash & Short-Term Investments	0	0	-
Prepaid Expenses	-	-	0.01
Total Current Assets	0	0	0.01
Total Assets	0	0	0.01
Accounts Payable	0.21	0.18	0.11
Short-Term Debt	0.27	0.25	0.17
Other Current Liabilities	0.02	0.02	0.02
Total Current Liabilities	0.49	0.44	0.29
Total Liabilities	0.49	0.44	0.29
Common Stock	0	0	0
Additional Paid-In Capital	5.2	5.2	5.15
Retained Earnings	-5.69	-5.64	-5.44
Total Common Equity	-0.49	-0.44	-0.28
Shareholders' Equity	-0.49	-0.44	-0.28
Total Liabilities & Equity	0	0	0.01
Total Debt	0.27	0.25	0.17
Net Cash (Debt)	-0.27	-0.25	-0.17
Net Cash Per Share	-0.01	-0.01	-0.00
Filing Date Shares Outstanding	38.96	38.96	34.74
Total Common Shares Outstanding	38.96	38.96	34.74
Working Capital	-0.49	-0.44	-0.28
Book Value Per Share	-0.01	-0.01	-0.01
Tangible Book Value	-0.49	-0.44	-0.28
Tangible Book Value Per Share	-0.01	-0.01	-0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.